US Stock MarketDetailed Quotes

COCP Cocrystal Pharma

Watchlist

2.3500
+0.0300+1.29%

Close Jan 3 16:00 ET

2.3500
0.00000.00%

Post 20:01 ET

23.91MMarket Cap-1.28P/E (TTM)

Cocrystal Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cocrystal Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Cocrystal Pharma Earnings Reports

Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Nov 13, 2024 15:33 ET

Cocrystal Pharma | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 08:32 ET

Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Aug 14, 2024 08:19 ET

Cocrystal Pharma | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 08:05 ET

Analyst Rating

Updated: Dec 31, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall